Solventum Co. (NYSE:SOLV) Receives $68.29 Average Target Price from Analysts

Shares of Solventum Co. (NYSE:SOLV) have been assigned a consensus recommendation of “Hold” from the eleven research firms that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is $68.29.

A number of analysts recently weighed in on the stock. Morgan Stanley upped their target price on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a report on Monday, November 11th. Mizuho started coverage on shares of Solventum in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price target for the company. Wolfe Research started coverage on shares of Solventum in a research note on Thursday, September 26th. They issued a “peer perform” rating for the company. Stifel Nicolaus started coverage on shares of Solventum in a research note on Tuesday, October 8th. They issued a “buy” rating and a $82.00 price objective for the company. Finally, Piper Sandler upped their price objective on shares of Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research note on Friday, November 8th.

Institutional Investors Weigh In On Solventum

Large investors have recently bought and sold shares of the company. MML Investors Services LLC lifted its holdings in Solventum by 3.2% in the 3rd quarter. MML Investors Services LLC now owns 5,345 shares of the company’s stock valued at $373,000 after purchasing an additional 168 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. grew its position in shares of Solventum by 4.2% during the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,966 shares of the company’s stock worth $346,000 after buying an additional 200 shares in the last quarter. National Bank of Canada FI boosted its holdings in Solventum by 4.0% in the second quarter. National Bank of Canada FI now owns 6,093 shares of the company’s stock valued at $314,000 after purchasing an additional 236 shares in the last quarter. IVC Wealth Advisors LLC lifted its stake in Solventum by 5.0% in the third quarter. IVC Wealth Advisors LLC now owns 6,649 shares of the company’s stock valued at $464,000 after buying an additional 318 shares during the last quarter. Finally, KKM Financial LLC lifted its stake in Solventum by 7.9% in the third quarter. KKM Financial LLC now owns 4,367 shares of the company’s stock valued at $304,000 after buying an additional 319 shares during the last quarter.

Solventum Stock Performance

Solventum stock opened at $72.72 on Friday. The firm’s 50 day simple moving average is $69.14 and its 200 day simple moving average is $65.29. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. Solventum has a 1-year low of $47.16 and a 1-year high of $96.05.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.